Box 1: Recent Trump Administration Obesity Drug Initiatives In November 2025, the Trump administration announced reaching a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1s for Medicare, Medicaid, and those purchasing the drugs directly from the manufacturers through a new TrumpRx website
Each compound is evaluated on its own terms by a provider
Instead of beginning with Which peptide should I take? the process begins with the patients symptoms, goals, medical history, medications, nutrition, recovery patterns, prior injuries, and risk factors
If you need daily or weekly injections, it will add up quickly
NI Peptides makes no representation regarding: biological effects in humans or animals clinical relevance therapeutic or diagnostic application All references to research relate strictly to experimental scientific investigation
The two core mechanism papers were retracted in April 2025 (Kawas 2012, PMID 22129598, retraction notice PMID 40312092